Cite
HARVARD Citation
Mehanna, H. et al. (2019). Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet. 393 (10166), pp. 51-60. [Online].